Navigation Links
Top Ten Pharma Company Deploys MedNet Solutions' Investigator Initiated Trial Management System
Date:3/19/2009

MINNETONKA, Minn., March 19 /PRNewswire/ -- MedNet Solutions, a global life sciences technology solutions company specializing in clinical study management systems, today announced that one of the world's largest pharmaceutical companies has deployed MedNet's Investigator Initiated Trial (IIT) Management System. This system provides a powerful, flexible and efficient solution to manage the entire IIT lifecycle... from proposal to publication... helping to ensure comprehensive, standardized and auditable IIT submissions, decisions and tracking on a world-wide basis.

"We are extremely pleased that MedNet has been selected to deliver the vital technology infrastructure required to fully automate, centralize and streamline the international IIT management processes of this industry leading pharmaceutical organization," stated John M. (Rob) Robertson, President and CEO of MedNet Solutions. "We believe this selection validates MedNet's continued commitment to providing the high level of expertise, technology and support needed to help life sciences organizations achieve operational efficiencies in all aspects of clinical research."

The MedNet IIT Management System delivers robust, highly configurable capabilities that allow pharmaceutical, medical device and biotechnology companies to achieve global IIT management standardization, increased IIT visibility, and reduced IIT program related time and cost expenditures. The solution also delivers the tools needed to shorten timelines from concept submission to publication, minimize redundant studies, and enhance investigator and management satisfaction.

About MedNet Solutions

MedNet Solutions is a leading healthcare technology company specializing in clinical study management systems designed for the global life sciences market. Applying critical insight, proven technology, and unwavering support, MedNet delivers powerful, flexible and easy-to-use web-based solutions that support our customers' clinical studies, registries and investigator initiated trials. Since 2000, MedNet has successfully supported leading pharmaceutical, medical device, and biotechnology organizations on projects spanning 6 continents and more than 40 countries. MedNet delivers a superior customer experience from beginning to end. For more information, please visit www.mednetstudy.com.

    Contact Information:
    Dirk H. Nelson
    Marketing Manager
    601 Carlson Parkway, Suite 605
    Minnetonka, MN  55305
    USA
    (763) 258-2735


'/>"/>
SOURCE MedNet Solutions
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. PharmAthene To Host Year-End 2008 Earnings Conference Call and Webcast on Monday, March 30, 2009
2. Frost & Sullivan Recognizes Novagali Pharma for Innovation in Ophthalmic Therapies
3. The Fitzsimons Redevelopment Authority Selects Pharmatech Oncology as Preferred Vendor
4. Maryland Business, Academic and Biopharma Groups Underscore Commitment to Medical Innovation, Finding Cures and Supporting the Economy
5. The Need for Safe and Affordable Biopharmaceuticals Drives the Development of the European Biosimilars Market, Says Frost & Sullivan
6. Quest PharmaTech Announces Strategic Alliance with IntelligentNano to Develop Nanotechnology-Based Next Generation SL052
7. Dr. Paul Korner Promoted to Senior Vice President of Ferring International PharmaScience Center U.S.
8. Tianyin Pharmaceutical Co., Inc. Adopts New Sales Strategy for Azithromycin Dispersible Tablets
9. PharmaNet Development Group Gives Notice of Anticipated Fundamental Change and Merger to Holders of Its Convertible Notes
10. Helix BioPharma Announces Q2 2009 Financial Results
11. RoundTable Healthcare Partners Facilitates Product Acquisition for CorePharma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)...  The Prostate Cancer Foundation (PCF) is pleased to announce 24 ... for prostate cancer. Members of the Class of 2016 were selected from a ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... , June 23, 2016   EpiBiome , a ... $1 million in debt financing from Silicon Valley Bank ... automation and to advance its drug development efforts, as ... facility. "SVB has been an incredible strategic ... services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... , ... June 23, 2016 , ... STACS DNA Inc., ... Leader at the Arkansas State Crime Laboratory, has joined STACS DNA as a Field ... DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
Breaking Biology Technology:
(Date:6/2/2016)... -- Perimeter Surveillance & Detection Systems, Biometrics ... Support & Other Service  The latest report ... analysis of the global Border Security market . ... $17.98 billion in 2016. Now: In November ... software and hardware technologies for advanced video surveillance. ...
(Date:5/12/2016)... WearablesResearch.com , a brand of Troubadour Research & ... Q1 wave of its quarterly wearables survey. A particular ... a program where they would receive discounts for sharing ... "We were surprised to see that so many ... CEO of Troubadour Research, "primarily because there are segments ...
(Date:4/26/2016)... and LONDON , ... Finacle, part of EdgeVerve Systems, a product subsidiary ... Onegini today announced a partnership to integrate the ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... provide their customers enhanced security to access and ...
Breaking Biology News(10 mins):